Sort
130,381 grants matching “hiv”
Multicenter AIDS Cohort Study
$901,232Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI
Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
$901,223William R Schief · Scripps Research Institute, The · R01 · FY2023 · AI
Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
$901,223William R Schief · Scripps Research Institute, The · R01 · FY2022 · AI
Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging
$901,152Adolf Pfefferbaum · Sri International · R01 · FY2025 · AA
Optimizing Humoral Responses to HIV-1 Env Vaccine Antigens
$901,125Garnett H Kelsoe · University Of Pennsylvania · P01 · FY2022 · AI
Immunogen design to elicit polyclonal bNAb responses to the V3 glycan supersite
$901,125Kevin Wiehe · University Of Pennsylvania · P01 · FY2022 · AI
Optimizing PrEP Implementation and Cost-effectiveness among Individuals with a Substance Use Disorder
$901,066Cathy J Reback · Friends Research Institute, Inc. · R01 · FY2025 · DA
DENVER COMMUNITY PROGRAM FOR CLINICAL RESEARCH ON AIDS (
$900,949Denver Health Medical Center · U01 · FY2001 · AI
HIV, Inflammation, and Endothelial Dysfunction
$900,940Samir Kumar Gupta · Indiana University Indianapolis · R01 · FY2009 · HL
HIV PREVENTION TRIALS UNIT-THAILAND
$900,918Johns Hopkins University · U01 · FY2001 · AI
Project SHIELD: Police Education to Support Public Health in Kentucky
$900,881Javier Cepeda · Johns Hopkins University · R61 · FY2024 · DA
NIMH COLLABORATIVE HIV/STD PREVENTION TRIAL
$900,847Johns Hopkins University · U10 · FY2002 · MH
Behavioral Sciences Training in Drug Abuse Research
$900,817Gregory P Falkin · New York University · T32 · FY2016 · DA
VIRUS-LIKE PARTICLES WITH STABILIZED TRIMERIC ENVELOPE FOR PRIME BOOST IMMUNIZATION
$900,802Shiu-Lok Hu · University Of Washington · R01 · FY2020 · AI
Targeting regulators of cellular gene transcription to impact HIV latency
$900,756Douglas D Richman · Veterans Medical Research Fdn/San Diego · P01 · FY2009 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children
$900,727Molly Forrest Franke · Harvard Medical School · U19 · FY2014 · AI
Drug Resistance Genotypic and Phenotypic Correlates of Efavirenz and Dolutegravir based Treatment Outcomes across Non-B HIV-1 subtypes
$900,704Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2019 · AI
ED2PrEP - patient focused, low-burden strategies for PrEP uptake among emergency departments patients: a cross-over hybrid implementation-effectiveness trial
$900,696Uriel Felsen · Albert Einstein College Of Medicine · R01 · FY2023 · AI
Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
$900,696C Robert Horsburgh · Boston University Medical Campus · R01 · FY2018 · AI
Preclinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
$900,515Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2014 · AI
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure
$900,458Alessandro Grattoni · Methodist Hospital Research Institute · R01 · FY2023 · AI
A type 2 hybrid effectiveness-implementation trial to evaluate a population health combination intervention to meet HIV testing, linkage, and viral suppression goals in coastal Alabama
$900,317Aadia Rana · University Of Alabama At Birmingham · R01 · FY2023 · AI
PrEP and ART adherence monitoring using dried blood spots
$900,286Peter Lindsay Anderson · University Of Colorado Denver · U01 · FY2016 · AI
Knockdown of Gene Expression in Immune Cells in Humanized Mice
$900,285Judy Lieberman · Boston Children'S Hospital · RC4 · FY2010 · AI
RETURN TO WORK WITH HIV/AIDS: NEUROPSYCHIATRIC FACTORS
$900,214Weill Medical College Of Cornell Univ · R01 · FY2000 · MH